Floatz logo

Pentoxifylline

Radiation Induced Lung Injury (RILI)

University Health Network, TorontoSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Radiation Induced Lung Injury (RILI) cohort.

Asset / SponsorPhaseRating
Alpha Tocopherol
University Health Network, Toronto
Phase 2CCC
[68ga]cbp8
Massachusetts General Hospital
Phase 2CCC
Durvalumab
Roswell Park Cancer Institute
Phase 2CCC
Nintedanib
Roswell Park Cancer Institute
Phase 2CCC

Same molecule, other indications

Pentoxifylline is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
76 / 100
View asset →
Neuralgia PeripheralDormant
BB
Indicative ·
69 / 100
View asset →
type 2 diabetes mellitusDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →